<?xml version="1.0" encoding="UTF-8" standalone="no"?><?xml-stylesheet type="text/css" href="uslm.css"?><bill xmlns="http://schemas.gpo.gov/xml/uslm" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" xsi:schemaLocation="http://schemas.gpo.gov/xml/uslm https://www.govinfo.gov/schemas/xml/uslm/uslm-2.0.10.xsd">
<!--Disclaimer: Legislative measures that include compacts or other non-standard data structures will require additional modeling and may contain inconsistencies in the converted USLM XML.-->
<meta><dc:title>116 HR 4761 ENR: To ensure U.S. Customs and Border Protection officers, agents, and other personnel have adequate synthetic opioid detection equipment, that the Department of Homeland Security has a process to update synthetic opioid detection capability, and for other purposes.</dc:title>
<dc:type>House Bill</dc:type><docNumber>4761</docNumber><citableAs>116 HR 4761 ENR</citableAs>
<citableAs>116hr4761enr</citableAs>
<citableAs>116 H.R. 4761 ENR</citableAs>
<dc:creator>United States House of Representatives</dc:creator><dc:publisher>United States Government Publishing Office</dc:publisher><dc:format>text/xml</dc:format><dc:language>EN</dc:language><dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights><docStage>ENR</docStage>
<processedBy>GPO Locator to USLM Converter 3.11.8;Stage2.20220127</processedBy><processedDate>2022-12-30</processedDate>
<congress>116</congress><session>2</session><publicPrivate>public</publicPrivate>
</meta>
<preface><dc:type>H. R.</dc:type><docNumber>4761</docNumber>

<congress style="-uslm-lc:I665502" value="116">One Hundred Sixteenth Congress of the United States of America</congress><session style="-uslm-lc:I665503" value="2">A T T  H  E S  E  C  O  N  D S  E  S  S  I  O  N</session>
<enrolledDateline style="-uslm-lc:I665504">Begun and held at the City of Washington on Friday, the third day of January, two thousand and twenty</enrolledDateline>
</preface>
<main>
<longTitle>
<docTitle class="centered fontsize18" style="-uslm-lc:I665505">An Act</docTitle>
<officialTitle class="centered fontsize8" style="-uslm-lc:I665511">To ensure U.S. Customs and Border Protection officers, agents, and other personnel have adequate synthetic opioid detection equipment, that the Department of Homeland Security has a process to update synthetic opioid detection capability, and for other purposes.<?GPOvSpace 08?></officialTitle>
</longTitle>
<enactingFormula style="-uslm-lc:I650120">  Be it enacted by the Senate and House of Representa­tives of the United States of America in Congress assembled,</enactingFormula>
<section id="d82672e62" identifier="/us/bill/116/hr/4761/s1" style="-uslm-lc:I650146"><num value="1">SECTION 1. </num><heading>SHORT TITLE.</heading><content style="-uslm-lc:I650120">  This Act may be cited as the “<shortTitle role="act">DHS Opioid Detection Resilience Act of 2019</shortTitle>”.</content></section>
<section id="d82672e72" identifier="/us/bill/116/hr/4761/s2" style="-uslm-lc:I650141"><num value="2">SEC. 2. </num><heading>STRATEGY TO ENSURE DETECTION OF ALL OPIOID PURITY LEVELS AT PORTS OF ENTRY.</heading><chapeau class="indentUp0 firstIndent1 fontsize10" style="-uslm-lc:I650120">  Not later than 180 days after the date of the enactment of this section, the Commissioner of U.S. Customs and Border Protection (CBP) shall—</chapeau><paragraph class="indentUp1 firstIndent1 fontsize10" id="d82672e78" identifier="/us/bill/116/hr/4761/s2/1" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">(1) </num><content>implement a strategy to ensure deployed chemical screening devices are able to identify in an operational environment narcotics at purity levels less than or equal to 10 percent, or provide ports of entry with an alternate method for identifying narcotics at lower purity levels; and</content></paragraph><paragraph class="indentUp1 firstIndent1 fontsize10" id="d82672e82" identifier="/us/bill/116/hr/4761/s2/2" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">(2) </num><content>require testing of any new chemical screening devices to understand the abilities and limitations of such devices relating to identifying narcotics at various purity levels before CBP commits to the acquisition of such devices.</content></paragraph></section>
<section id="d82672e87" identifier="/us/bill/116/hr/4761/s3" style="-uslm-lc:I650141"><num value="3">SEC. 3. </num><heading>PLAN TO ENSURE OPIOID DETECTION EQUIPMENT RESILIENCY.</heading><chapeau class="indentUp0 firstIndent1 fontsize10" style="-uslm-lc:I650120">  Not later than 180 days after the date of the enactment of this section, the Secretary of Homeland Security shall implement a plan for the long-term development of a centralized spectral database for chemical screening devices. Such plan shall address the following:</chapeau><paragraph class="indentUp1 firstIndent1 fontsize10" id="d82672e93" identifier="/us/bill/116/hr/4761/s3/1" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">(1) </num><content>How newly identified spectra will be collected, stored, and distributed to such devices in their operational environment, including at ports of entry.</content></paragraph><paragraph class="indentUp1 firstIndent1 fontsize10" id="d82672e97" identifier="/us/bill/116/hr/4761/s3/2" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">(2) </num><content>Identification of parties responsible for updates and maintenance of such database.</content></paragraph></section>
</main>
<signatures>
<signature><role style="-uslm-lc:I650114">Speaker of the House of Representatives.</role></signature>
<signature><role style="-uslm-lc:I650114">Vice President of the United States and  President of the Senate.</role></signature>
</signatures>
</bill>